Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock
Amylyx Pharmaceuticals priced an upsized underwritten public offering of 14.09 million shares at $35.50 per share, targeting gross proceeds of approximately $500.2 million. Underwriters were granted a 30-day option to purchase an additional 2.11 million shares at the public offering price.
Key figures
- Deal Value Usd
- $500.2 million
- Offering Price
- $35.50
- Shares Offered
- 14090000
- Underwriters option shares
- 2113500
- Underwriters option duration days
- 30
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.